Disclosed herein are methods, devices and systems of treating dysfunctional biochemical pathway(s) using an individualized treatment plan (ITP) of metabolic support intervention(s) for a patient. The ITP has metabolic support intervention(s) that restore proper functioning of biochemical pathway(s) correcting dysfunction(s) therein. Methods can include determining if the biochemical pathway(s) are dysfunctional by subjecting, via a bio-communication device, the patient to a noninvasive test that includes simulating one or more stimuli that are indicative of the biochemical pathway(s)' s functioning. Methods can include developing the ITP by subjecting, via the bio-communication device, the patient to a noninvasive test that includes simulating metabolic support intervention(s) to identify those that support restoration of proper functioning to the biochemical pathway(s); adding those that support restoration of proper functioning to the biochemical pathway(s); and periodically revising the ITP as re-evaluation of the patient reflects the “then-current” biochemical status of the patient. Methods include implementing the ITP.
Legal claims defining the scope of protection, as filed with the USPTO.
1. A method for treating a metabolic network of a patient, the method comprising: establishing a metabolic baseline of fundamental biochemical pathways of the patient by measuring, using a bio-communication device, a baseline value of fundamental biochemical pathways in a body of the patient without stimuli or stressors not generated by the bio-communication device; testing the metabolic baseline by simulating, with the bio-communication device, one or more pre-selected stimuli or stressors, which cause a response in the patient that is indicative of a health status of the fundamental biochemical pathways of the patient, from a library of one or more stimuli or stressors and measuring, with the bio-communication device, the response of the patient to the one or more pre-selected stimuli or stressors; generating, with the bio-communication device, an assessment reading corresponding to the metabolic baseline and the response of the patient to the one or more pre-selected stimuli or stressors that have been simulated; identifying one or more metabolic dysfunctions in the metabolic baseline by comparing, with bio-communication software, the response of the patient to the one or more pre-selected stimuli or stressors that have been simulated to the metabolic baseline; determining that the patient has a dysfunctional fundamental biochemical pathway based on the one or more metabolic dysfunctions that have been identified and one or more evaluation protocols; assessing a metabolic treatment plan for correcting the one or more metabolic dysfunctions by simulating, with the bio-communication device, one or more metabolic supports or support interventions from a library of one or more metabolic supports or support interventions, wherein each of the metabolic supports or support interventions facilitate restoration of proper fundamental biochemical pathway functioning, and measuring, with the bio-communication device, the response of the patient to the one or more metabolic supports or support interventions that have been simulated; developing a prescribed metabolic treatment plan by adding, based on the assessment, one or more metabolic supports or support interventions to the prescribed metabolic treatment plan if the response of the patient to the one or more metabolic supports or support interventions that have been simulated indicates restoration of proper fundamental biochemical pathway functioning to the dysfunctional fundamental biochemical pathway and refraining from adding, based on the assessment, the one or more metabolic supports or support interventions to the prescribed metabolic treatment plan if the response of the patient to the one or more metabolic supports or support interventions that have been simulated does not indicate restoration of proper fundamental biochemical pathway functioning to the dysfunctional fundamental biochemical pathway; and implementing the prescribed metabolic treatment plan to support the dysfunctional fundamental biochemical pathway of the patient to restoration of proper functioning.
2. The method of claim 1 , wherein the bio-communication device uses an electrodermal test to measure one or more of the metabolic baseline of the fundamental biochemical pathways in the body of the patient without the stimuli or stressors not generated by the bio-communication device, the response of the patient to the stimuli or stressors, and the response of the patient to the one or more metabolic supports or support interventions that have been simulated.
3. The method of claim 1 , wherein the one or more evaluation protocols comprises one or more of a physical exam of the patient, a patient interview, or a lab test.
4. The method of claim 1 , wherein the metabolic baseline comprises one or more of protein metabolism, fat metabolism, carbohydrate metabolism, urea cycle, transsulfuration, and liver detoxification pathways or pathways connected thereto.
5. The method of claim 1 , wherein the library of one or more stimuli or stressors includes one or more of pathogens, allergens, nutritional deficiencies, physical stress or injury, emotional stress, pollution, toxin exposure and buildup, overwork and lack of rest, viruses, bacteria, and toxins.
6. The method of claim 1 , wherein the library of one or more metabolic supports or support interventions comprises one or more of dietary modifications, nutrient supplements, homeopathic remedies, botanicals, enzymes, energetic treatments, or acupuncture points.
7. The method of claim 1 , wherein the metabolic treatment plan further comprises a metabolic treatment plan period and wherein the metabolic treatment plan period includes time for the patient to administer the one or more metabolic supports or support interventions in the prescribed metabolic treatment plan and for the body of the patient to restore the fundamental biochemical pathways.
8. The method of claim 7 , wherein the method further comprises: awaiting expiration of the metabolic treatment plan period; retesting the metabolic baseline after the metabolic treatment plan period to re-evaluate the health status of the fundamental biochemical pathways of the patient by simulating, with the bio-communication device, one or more pre-selected stimuli or stressors, which cause a response in the patient that is indicative of the health status of the fundamental biochemical pathways of the patient, from a library of one or more stimuli or stressors and remeasuring, with the bio-communication device, the response of the patient to the one or more pre-selected stimuli or stressors that have been simulated; generating, with the bio-communication device, a reassessment reading corresponding to the metabolic baseline and the response of the patient to the one or more pre-selected stimuli or stressors that have been simulated from retesting the metabolic baseline; reidentifying one or more metabolic dysfunctions in the metabolic baseline by comparing, with the bio-communication software, the response of the patient to the one or more pre-selected stimuli or stressors that have been simulated from retesting the metabolic baseline to the metabolic baseline; re-determining that the patient has the dysfunctional fundamental biochemical pathway based on the one or more metabolic dysfunctions that have been reidentified and the one or more evaluation protocols; assessing a modified metabolic treatment plan for correcting the one or more metabolic dysfunctions that have been reidentified by simulating, with the bio-communication device, one or more metabolic supports or support interventions from the library of one or more metabolic supports or support interventions, wherein each of the metabolic supports or support interventions facilitate restoration of proper fundamental biochemical pathway functioning, and measuring, with the bio-communication device, the response of the patient to the one or more metabolic supports or support interventions that have been simulated, wherein the modified metabolic treatment plan is different from the prescribed metabolic treatment plan; developing a modified prescribed metabolic treatment plan by adding, based on the reassessment, the one or more metabolic supports or support interventions to the modified prescribed metabolic treatment plan if the response of the patient to the one or more metabolic supports or support interventions that have been simulated indicates restoration of proper fundamental biochemical pathway functioning to the dysfunctional fundamental biochemical pathway and refraining from adding, based on the reassessment, the one or more metabolic supports or support interventions to the modified prescribed metabolic treatment plan if the response of the patient to the one or more metabolic supports or support interventions that have been simulated does not indicate restoration of proper fundamental biochemical pathway functioning to the dysfunctional fundamental biochemical pathway; and implementing the modified prescribed metabolic treatment plan to support the dysfunctional fundamental biochemical pathway of the patient to restoration of proper functioning.
9. The method of claim 1 , wherein the prescribed metabolic treatment plan includes one or more metabolic supports or support interventions corresponding to a first dysfunctional fundamental biochemical pathway, the method further comprising, after proper functioning of the first dysfunctional fundamental biochemical pathway has been restored, providing a supplemental metabolic treatment plan that includes one or more metabolic supports or support interventions for a second dysfunctional fundamental biochemical pathway.
10. The method of claim 9 , wherein a deficiency in the first dysfunctional fundamental biochemical pathway is greater than the deficiency in the second dysfunctional fundamental biochemical pathway.
11. The method of claim 1 , wherein, if the dysfunctional fundamental biochemical pathway is an elimination or degradation pathway, the prescribed metabolic treatment plan includes one or more metabolic supports or support interventions for restoring elements toward an end of the dysfunctional fundamental biochemical pathway, and if the dysfunctional fundamental biochemical pathway is a bio-synthesis pathway, the prescribed metabolic treatment plan includes one or more metabolic supports or support interventions for restoring elements toward a beginning of the dysfunctional fundamental biochemical pathway.
12. The method of claim 1 , wherein providing the prescribed metabolic treatment plan includes providing a metabolic maintenance plan for maintaining proper functioning of one or more previously treated dysfunctional fundamental biochemical pathways.
13. The method of claim 1 , wherein the prescribed metabolic treatment plan includes one or more metabolic supports or support interventions for simultaneously treating each dysfunctional fundamental biochemical pathway.
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
April 26, 2014
October 27, 2020
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.